B7-H3/CD276 Antibody (enoblituzumab) [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28383APC
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # enoblituzumab
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for B7-H3/CD276 Antibody (enoblituzumab) [Allophycocyanin]
Immunogen
B7-H3 / CD276
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Applications for B7-H3/CD276 Antibody (enoblituzumab) [Allophycocyanin]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: B7-H3
Long Name
B7 Homolog 3
Alternate Names
B7H3, CD276
Gene Symbol
CD276
Additional B7-H3 Products
Product Documents for B7-H3/CD276 Antibody (enoblituzumab) [Allophycocyanin]
Product Specific Notices for B7-H3/CD276 Antibody (enoblituzumab) [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...